Quick Answer
WEST PHARMACEUTICAL SERVICES INC reported Research And Development Expense of $74.30 million for the year ending 2025.
- WEST PHARMACEUTICAL SERVICES INC showed an increase of +7.5% in Research And Development Expense from 2024 to 2025.
- This data is from WEST PHARMACEUTICAL SERVICES INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), WEST PHARMACEUTICAL SERVICES INC's Research And Development Expense has grown by 297.3%.
- Historical annual values: Fiscal year 2025: $74.30 million | Fiscal year 2024: $69.10 million | Fiscal year 2023: $68.40 million | Fiscal year 2022: $58.50 million | Fiscal year 2021: $52.80 million | Fiscal year 2020: $46.90 million | Fiscal year 2019: $38.90 million | Fiscal year 2018: $40.30 million | Fiscal year 2017: $39.10 million | Fiscal year 2016: $36.80 million | Fiscal year 2015: $34.10 million | Fiscal year 2014: $37.30 million | Fiscal year 2013: $37.90 million | Fiscal year 2012: $33.20 million | Fiscal year 2011: $29.10 million | Fiscal year 2010: $23.90 million | Fiscal year 2009: $19.90 million | Fiscal year 2008: $18.70 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: